Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS Data)

American Journal of Cardiology

Volumn 108, Issue 4, 2011, Pages 541-547

  Greve, Anders M ^a   Gerdts, Eva ^b,h   Boman, Kurt ^c   Gohlke Baerwolf, Christa ^d   Rossebø, Anne B ^e   Hammer Hansen, Sophia ^a   Køber, Lars ^a   Willenheimer, Ronnie ^f   Wachtell, Kristian ^a,g  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF BERGEN   (Norway)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; DIGOXIN; GLUCOSE; URIC ACID;

AGED; AORTA STENOSIS; ARTICLE; ATRIOVENTRICULAR BLOCK; BODY SURFACE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEART ARREST; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; ST SEGMENT DEPRESSION; SYSTOLIC BLOOD PRESSURE;

EID: 79960915739     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.084     Document Type: Article

References (15)

1. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268. (Pubitemid 46276943)
2. Lester SJ, Heilbron B, Gin K, Dodek A, Jue J. The natural history and rate of progression of aortic stenosis. Chest 1998;113:1109-1114. (Pubitemid 28216461)
3. Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Design and baseline characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. Am J Cardiol 2007;99:970-973. (Pubitemid 46483289)
4. Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-1356.
5. Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Bristol: John Wright, 1982:298
6. Rieck AE, Cramariuc D, Staal EM, Rossebø AB, Wachtell K, Gerdts E. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). J Hypertens 2010;28:377-383.
7. Carabello BA. What is new in the 2006 ACC/AHA guidelines on valvular heart disease? Curr Cardiol Rep 2008;10:85-90.
8. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quiñones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10:1-25.
9. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458. (Pubitemid 16119719)
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463. (Pubitemid 41821197)
11. Siegel RJ, Roberts WC. Electrocardiographic observations in severe aortic valve stenosis: correlative necropsy study to clinical, hemodynamic, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient. Am Heart J 1982;103:210-221. (Pubitemid 12162050)
12. Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlöf B, Aalto T, Roman MJ, Papademetriou V, Ibsen H, Rokkedal J, Devereux RB. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000;35:6-12. (Pubitemid 30054229)
13. Friedman HS, Zaman Q, Haft JI, Melendez S. Assessment of atrioventricular conduction in aortic valve disease. Br Heart J 1978;40:911-917. (Pubitemid 9011134)
14. Nair CK, Aronow WS, Stokke K, Mohiuddin SM, Thomson W, Sketch MH. Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium. Am J Cardiol 1984;53:169-172. (Pubitemid 14217528)
15. Selzer A, Lombard JT. Clinical findings in adult aortic stenosis - then and now. Eur Heart J 1988;9(suppl E):53-55.